Dendritic Cell Strategies May Reduce Cancer Recurrence Risk Carole Stavart Medscape Europe April 16, 2026

https://www.medscape.com/viewarticle/dendritic-cell-strategies-may-reduce-cancer-recurrence-risk-2026a1000bxp Damya Laoui, PhD, a bioengineer and immunologist at the Brussels Center for Immunology of the Department of Bioengineering Sciences in Brussels, Belgium, and the Flemish Institute of Biotechnology in Ghent, Belgium, is investigating how dendritic cells within tumors may be used to reduce the risk for cancer recurrence.